Introductions: Hair loss is common after bariatric surgery. This study analyzes the extent and risk factors of hair loss following laparoscopic sleeve gastrectomy (LSG), and satisfaction of self-prescribed supplements.
Introductions
Obesity has increased and so is the comorbidities like type 2 diabetes, hypertension, obstructive sleep apnea, polycystic ovary syndrome, hyperlipidemia and coronary heart diseases. [1] [2] [3] Patients suffering from obesity requires persisting changes to healthy lifestyle to reduce weight, otherwise rebound occurs in up to 90% after six months. 4 In year 2011, over 340,000 bariatric procedures were performed worldwide. 5 The curative effect of bariatric surgery for patients suffering from obesity is nearly 100%. 6 Laparoscopic sleeve gastrectomy (LSG) has become a standalone bariatric surgery procedure of choice for obesity and is preferred because of its technical efficiency, less operation time, minimal blood loss, and excellent weight reduction. However, in common to other bariatric procedures, LSG share the frustrating psychological distress and quality of life issue due to hair loss after surgery. [7] [8] [9] Various nutritional interventions have failed to solve this problem.
The aim of this study was to analyze the risk factors for hair loss after LSG so as patient can be counseled and appropriate measures implemented.
Methods
The cohort obese patients who underwent primary LSG during June 2013 to August 2016 at Shanghai East Hospital, Tongji University, Shanghai, formed the study cohort. All patients were informed about the study and gave signed consent to participate. The study was approved from the ethical committee of the university. Patients with revision LSG, hair conditions such as bald, significant preoperative hair loss, obvious scalp infections and incomplete follow up data after surgery were excluded from final analysis, (Figure 1 ).
Patients were assessed during out-patient department (OPD) visits at one month after surgery. Further OPD visits were not mandatory and only on voluntary basis if the patients felt the need to visit the hospital. They were provided with the structured follow up chart and advised to complete the documentation at 3, 6, 9 and 12 months for weight loss, starting (start of hair fall) and ending (stoppage of hair fall and regrowth of new hair) times of hair loss, degree of hair loss (as per the provided pictorial images of mild, moderate and severe hair loss, (Figure  2a and 2b) . We used Ludwig grading for severity of hair loss because most of our patients were female. 10, 11 We used WeChat (free messaging and calling electronic social media platform common in China), text messages and email to collect patient selfreported data. Uses of nutritional supplements by patients were recorded as well as satisfaction of patients to prevent hair loss or enhance hair growth (determined by patients themselves).
Logistic regression model and regression equation were used to predict the risk factors for hair loss. Thirteen variables were taken as covariates and divided into X1~X13 respectively. The severity of hair loss was taken as variable (no or mild hair loss group and moderate to severe hair loss group) and set to Y. The gender and the degree of hair loss were classified as qualitative data. The quantitative methods used were: gender (X2) = 0 for male and 1 for female; postoperative hair loss severity (Y) = 1 for moderate to severe hair loss, and 0 for no hair loss or mild hair loss. The other 12 variables-age (X1), preoperative BMI (X3), total cholesterol (X4), albumin (X5), hemoglobin (X6), iron (X7), zinc (X8), copper (X9), folic acid (X10), vitamin B12 (X11), vitamin D (X12), %EWL (X13) itself were the quantitative data.
Statistical software SPSS 20.0 was used to analyze the data and expressed as mean ± standard deviation (X ± SD). The χ2 test was used for comparative analysis and P values <0.05 were considered statistically significant. 
Results
There were 86 patients who had LSG. Fifteen were excluded as per initial recruitment criteria and from remaining 71 obese patients (M=13, F=58) formed the study cohort. Their mean age was 30.5±7.49 years, BMI 35.3±7.1Kg/m², comorbiditiestype-2 diabetes 13 (18.3%), polycystic ovary syndromes 10 (14.1%), sleep apnea 8 (11.2%) and hypertension in 7 (9.9%). There was no postoperative bleeding, gastric leakage, obstruction and mortality. Among 71 patients, 17 had incomplete follow-up data and were excluded from final analysis. The one step single variate analysis showed that the χ2 values among the Model, Block and Step were same, ( Table 3 ). The P value was 0.001<0.05. The coefficients of the covariant were not all 0, which showed significant differences of the model.
On multivariate regression analysis of 13 covariates, the gender (correlation coefficient B = 4.850, P = 0.033), preoperative folic acid (B = -0.644, P = 0.018) and %EWL (B = 2.808, P = 0.027) had a significant effect on moderate to severe hair loss (strain Y), and rest of the variables had no significant effect on hair loss, ( Table 4 ).
The regression equation of the factors of hair loss was established by the regression coefficient of each variable. We set the risk rate of moderate to severe hair loss at P, logit (p)=-9.756+0.060 X1+4.280 X2-0.020 X3-1.499 X4-0.023 X5+0.070 X6+0.849X7-0.131 X8+0.349 X9-0.680 X10-0.007 X11+0.011 X12+2.504 X13. Then we randomly selected 5 cases with moderate to severe hair loss. The predicating results were same as the follow-up results, indicating that the model was satisfactory.
Discussions
In our study hair loss was reported by 3/4 th of patients (77.8% i.e. 42 of 54) following LSG for obesity. Female patients reported hair loss more commonly (36 out of 42), and with high severity as all 11 severe hair losses were seen in female.
Different grades of hair loss have been reported after bariatric surgery. It occurs usually after 3 months following bariatric procedures.
12-15 Hair loss is reported in up to 74.2%. 16 Diffuse type of hair loss known as telogen effluvium is common. Stress due to surgery and enforced dietary regimen causes the hair cycle shift to the telogen phase or resting phase with continued hair loss.
17,18
Some studies have also shown that excessive weight loss causes damage in some components of the cutaneous extracellular matrix of the hair causing hair loss. 19, 20 Various micronutrients have been associated with the hair loss. Study reports hair loss in 16 (38% in 42) obese patients undergoing LSG and were significantly associated with low plasma zinc levels (P=0.021). 8 Reduction of gastric acid following sleeve gastrectomy reduces zinc absorption. Reports shows that the patients taking higher supplements of iron and zinc had milder hair loss than the patients taking lower supplements.
14 However, in a study conducted on 130 patients undergoing bariatric surgery showed that 47 patients still had hair loss despite the iron and vitamin supplement. 7 In our study we didn't find significant correlation between hair loss and preoperative levels of zinc or iron. We did not monitor post-operative levels of these minerals and thus cannot conclude with certainty whether the postoperative levels of these minerals were significant low and played a role in hair fall. However, 15 patients who did use self-prescribed various nutrition supplements (6 had zinc, 4 iron, 3 iron plus zinc and 2 zinc plus vitamin B12) available in the market without prescription (Table 2) did not report satisfactory benefits. The use of various supplements and results were all selfreported by patients, and the accurate dose and their effect could not be analyzed in detail, one of the possible limitations of our study. Iron supplements were not required for at least one year after surgery in patients undergoing LSG. 21 In our study, the mean starting time of hair loss was 3.43±1.36 months after surgery. This is the period of rapid decline in the body weight after surgery. The highest weight loss occurs in the first six months of the surgery.
22
The greater the %EWL, faster the weight loss and more serious is the hair loss. Possible explanation of this early hair loss could be rapid subcutaneous adipose tissue decrease after LSG, making scalp structure thinner, reducing the strength needed to support hair and resulting in hair loss. The thinning of the scalp tissue may also decrease blood supply and nutrient to the hair follicle which could further weaken the hair causing the hair to advance into the 'telogen phase'. These are the areas of further research. Women with longer hair require more strength of scalp to support the hair. This may be the reason of higher and severe hair loss in female. A few months after the LSG, the body adapts to the changing environment, the scalp structure gradually stabilizes and so the hair loss stops. At this time, the 'telogen phase' re-enters the hair growth phase. Folic acid as a carbon unit carrying molecules plays important role in protein synthesis 23, 24 The folic acid deficiency may affect synthesis of kerato-proteins, leading to hair loss.
The small sample size and patient selfreported follow up may have biased reporting for the severity of hair loss. Similarly, the use of self-prescribed supplements, lack of details about the dose and duration and objective measure of satisfaction are some of the limitations of our study. Majority of our patients with hair loss were females, (F:M= 36:6), and so the Ludwig grading system we used may not justify for the male patients. All patients in this study had LSG, and resulting hair loss may not be generalized to other bariatric procedures. This was the beginning of LSG bariatric procedure at our center, and the number of procedures has increased significantly thereafter.
This study high lights the extent of problem of hair loss after LSG in majority (77.8%, 42 of 54 patients had hair loss) and there were more than 1/3 patients (35.7%, 15 of 42 with hair loss) who experienced stress due to hair loss and were desperate to try various selfprescribed supplements. Our study points out the significance of preoperative serum folic acid, and %EWL and certain risk factors like female gender for hair loss following LSG. These findings may be useful to counsel female patients and prepare them for this self-limiting stressful postoperative situation, and also the fact that there is no proven benefit of self-medication of supplements available in the market. Taking into consideration the limitation of our study, and findings of no benefit of self-prescribed iron and zinc supplements, there is need of prospective comparative study design to further consolidate these issues.
Current study shows that there was no reported satisfactory benefit of selfprescribed nutritional supplements containing iron, and zinc. Hair loss was a self-limiting common phenomenon after LSG bariatric surgery, seen in 3/4 th (77.8%, 42 of 54) of patients starting at 3.43±1.36 months and ending at 8.59±3.38 months (in 39 out of 42). Multivariate regression analysis showed female gender, preoperative serum folic acid, and %EWL (3 out of 13 covariates) as risk factors for hair loss.
Conclusions
Hair loss was seen in up to 3/4 th of patents after Laparoscopic sleeve gastrectomy bariatric surgery. Postoperatively 1/3 of patients used self-prescribed nutrition supplements for hair loss with no satisfactory results. Female gender, preoperative serum folic acid, and postoperative excess weight loss (%EWL) were significant risk factors for hair loss.
